Conavi Medical Corp.
CNVIF
$0.27
$0.001.09%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -92.98% | 319.91% | 148.09% | 179.57% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -92.98% | 319.91% | 148.09% | 179.57% | -- |
| Cost of Revenue | -101.62% | -31.37% | -17.77% | 20.30% | -- |
| Gross Profit | -89.17% | 88,008.06% | 426.58% | 398.40% | -- |
| SG&A Expenses | -8.18% | -15.77% | -12.10% | 13.72% | -- |
| Depreciation & Amortization | -15.98% | -18.87% | -20.98% | -25.57% | -- |
| Other Operating Expenses | 13.09% | 26.46% | -1.21% | -1.21% | -- |
| Total Operating Expenses | -33.56% | -19.03% | -17.77% | 8.08% | -- |
| Operating Income | 5.45% | 45.87% | 40.61% | 16.04% | -- |
| Income Before Tax | 63.23% | 53.91% | 15.02% | -39.82% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 63.23% | 53.91% | 15.02% | -39.82% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.23% | 53.91% | 15.02% | -39.82% | -- |
| EBIT | 5.45% | 45.87% | 40.61% | 16.04% | -- |
| EBITDA | 5.03% | 46.45% | 40.80% | 15.28% | -- |
| EPS Basic | 96.04% | 94.67% | 48.45% | -9.67% | -- |
| Normalized Basic EPS | 94.62% | 95.45% | 67.78% | 27.65% | -- |
| EPS Diluted | 96.04% | 94.67% | 48.45% | -9.67% | -- |
| Normalized Diluted EPS | 94.62% | 95.45% | 67.78% | 27.65% | -- |
| Average Basic Shares Outstanding | 355.23% | 833.82% | 545.81% | 292.60% | -- |
| Average Diluted Shares Outstanding | 355.23% | 833.82% | 545.81% | 292.60% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |